drugset / Trial / NCT00459173
Efficacy and Safety of Rimonabant as an Aid to Maintenance of Smoking Cessation
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary study objective is to evaluate the efficacy of 2 dose levels of rimonabant (5 mg and 20 mg) for the maintenance of abstinence from smoking. Secondary objectives are to evaluate the effect of rimonabant on craving and weight, the clinical and biological safety of 2 doses of rimonabant rimonabant during a 12-month treatment period and to evaluate the pharmacokinetics of the drug.
Timeline
- Start
- 2002-11
- Primary completion
- 2005-09
- Completion
- 2005-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rimonabant | Small molecule | 5 mg | — |
| Subject | Rimonabant | Small molecule | 20 mg | — |
Indications
No indication recorded.